+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Lymphogranuloma Diagnostic"

Lymphogranuloma Diagnostics Market 2024: US, Europe, Japan - Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies - Product Thumbnail Image

Lymphogranuloma Diagnostics Market 2024: US, Europe, Japan - Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies

  • Report
  • August 2024
  • Japan, United States, ... Japan, United States, Europe
From
2022-2026 Global Lymphogranuloma Testing in 90 Countries - Product Thumbnail Image

2022-2026 Global Lymphogranuloma Testing in 90 Countries

  • Report
  • December 2021
  • Global
From
2024-2028 Global Lymphogranuloma Testing in 90 Countries: Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation - Product Thumbnail Image

2024-2028 Global Lymphogranuloma Testing in 90 Countries: Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

  • Report
  • October 2024
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

The Lymphogranuloma Diagnostic market is a subset of the Diagnostics industry, focusing on the diagnosis of lymphogranuloma venereum (LGV). This sexually transmitted infection is caused by a type of Chlamydia bacteria and is most common in tropical and subtropical regions. Diagnosis of LGV is typically done through a combination of physical examination, laboratory tests, and imaging. Treatment typically involves antibiotics, and in some cases, surgery. The Lymphogranuloma Diagnostic market is highly competitive, with a number of companies offering products and services. These include Abbott Laboratories, Becton Dickinson, Bio-Rad Laboratories, Cepheid, DiaSorin, Hologic, and Roche Diagnostics. Show Less Read more